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Biochimie Structurale, Montpellier, FranceABSTRACT Sickle cell anemia is a blood disorder, known to affect the microcirculation and is characterized by painful vaso-
occlusive crises in deep tissues. During the last three decades, many scenarios based on the enhanced adhesive properties of
the membrane of sickle red blood cells have been proposed, all related to a final decrease in vessels lumen by cells accumu-
lation on the vascular walls. Up to now, none of these scenarios considered the possible role played by the geometry of the flow
on deposition. The question of the exact locations of occlusive events at the microcirculatory scale remains open. Here, using
microfluidic devices where both geometry and oxygen levels can be controlled, we show that the flow of a suspension of sickle
red blood cells around an acute corner of a triangular pillar or of a bifurcation, leads to the enhanced deposition and aggregation
of cells. Thanks to our devices, we follow the growth of these aggregates in time and show that their length does not depend on
oxygenation levels; instead, we find that their morphology changes dramatically to filamentous structures when using autolo-
gous plasma as a suspending fluid. We finally discuss the possible role played by such aggregates in vaso-occlusive events.INTRODUCTIONSickle cell anemia (SCA) is an inherited hemoglobinopathy
(1) affecting millions of people worldwide (2). It is caused
by a point mutation resulting in the production of abnormal
hemoglobin called hemoglobin S (HbS) (3). When deoxy-
genated, HbS molecules polymerize into long fibers (4),
which can span the size of the red blood cell (RBC), distort-
ing it into the classical crescent shape at rest (5,6). Such
polymerization reduces the deformability of RBCs and
reduces their lifespan (7–9), leading to anemia.
Originally, the stiffening of RBCs has been blamed for
possibly causing vaso-occlusive events, qualifying SCA as
a hemorheological disease (10,11). In this scenario, the
obstruction process would be a competition between hydro-
dynamic forces that push the cells through the smallest
capillaries to provide oxygen to the tissues and the polymer-
ization of the fibers that occlude further transport of blood
cells either by steric confinement in smaller capillaries
(12), or by collective jamming of larger postcapillary
venules (10,11), due to the loss of RBCs deformability
and blood rheo-thickening.
However, during the last three decades, the pathophysi-
ology of vaso-occlusion has proven to be more complex
(13,14). While nearly all patients with SCA demonstrate
chronic anemia, the clinical expression of the disease differs
from one patient to another. It is now well admitted that
vaso-occlusive events depend not only on the mechanicalSubmitted October 10, 2014, and accepted for publication April 14, 2015.
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but also on their ability to adhere to each other and to the
vascular walls, an ability that is dependent upon inflamma-
tory and oxidative stresses (15–17)).
Surprisingly, the role of the geometry where the vaso-
occlusive events takes place has not been explored up to
now. The microcirculatory network is highly branched and
has a reticulated nature, because it is designed to perfuse
efficiently and deeply into tissues. In these microcapillaries,
80% of the total pressure-drop between the aorta and the
vena cava occurs (18), making it a critical place for distur-
bances. In addition, such microvessels generally present
strong bends and wavy shapes, with short segment lengths
between bifurcations, which tends to attenuate the formation
of a cell-depleted layer adjacent to the vessels wall (19).
These features could play a major role in vaso-occlusion
when coupled to the adhesive properties of SRBCs. Even
though the structure and geometry of the microcirculatory
network has been poorly documented in SCA patients, pre-
liminary results in the skeletal muscle of patients with sickle
cell trait (20), in the liver (21), or in the conjunctival micro-
circulation (22) of patients with Sickle Cell Disease indicate
important changes: a rarefaction of microvessels in the
network, a decrease of their tortuosity, and an enlargement
of their diameter. These characteristics all point to a physi-
ological relevance that remains to be understood in the
context of RBC adhesion, stiffening, and flow. There is a
clear need to integrate both the rheological and the adhesive
points of view in a more unified vision and to study the vaso-
occlusion dynamics both at the cellular scale and in flow,http://dx.doi.org/10.1016/j.bpj.2015.04.018
2624 Loiseau et al.because the problem of obstruction is in essence a circula-
tory one.
We used microfluidic channels as a first step to explore
the potential effects of flow geometry coupled to adhesion
and polymerization on vaso-occlusion. We focused our
attention to test the jamming scenario of vaso-occlusion in
straight channels by designing microchannels with gas
exchange that mimic physiological conditions of the micro-
circulation in terms of flow velocity, oxygen concentration,
and hematocrit. While none of our experiments in straight
channels showed clogging at physiologically relevant
velocities, we observed intense deposition of SRBCs and
the formation of SRBCs aggregates around acute corners
where the flow changes rapidly, in a direction typical of bi-
furcations in vivo. Such aggregates might play a major role
in vaso-occlusive events, linking adhesive properties of the
membrane of the cells with flow characteristics.MATERIALS AND METHODS
Blood samples
Blood samples were collected during the normal course of patient care at
the Montpellier University Hospitals Hematology Laboratory (Montpellier,
France), according to a research protocol (IRB 12/12-04) approved by the
Partners Healthcare Institutional Review Board. Blood is collected in
EDTA tubes, and the Mean Corpuscular Hemoglobin Concentration
(MCHC) as well as the HbS percentage were determined by the hematology
laboratory. All the samples containing HbS came from seven different
patients with a homozygous genotype (HbSS) just before their exchange
transfusion. The samples used in this study and their properties are listed
in Table 1. RBCs are washed by successive centrifugation in a PBS (phos-
phate-buffered saline) solution containing 5 mM glucose, the final osmotic
pressure being adjusted to 300 mOsm. RBCs are then resuspended at 50%
hematocrit. In order to get samples with a narrow MCHC, RBCs are sepa-
rated according to their density (and therefore according to the hemoglobin
concentration) on a discontinuous Percoll (Cat. No. 77237; Sigma-Aldrich,
St. Louis, MO) density gradient, following a protocol adapted from Corbett
et al. (6). The gradient is centrifuged at 4000 g for 1 h at 4C and then,
SRBCs settling between the Percoll layers of density 1.092 and 1.101 (cor-
responding to a MCHC of 0.34 g/cm3) were harvested with a micropipette.
To get rid of the Percoll, the SRBCs are washed five times in a PBSþ 5 mM
glucose solution adjusted to 300 mOsm and finally resuspended at 50%
hematocrit for storage at 4C. Blood samples were used within a maximumTABLE 1 List of blood samples used during the experiments
Sample % HbS
Extra
Free HbS
Autologous
Plasma Patient Test
1 79.7 no no patient 1 clogging
2 59.2 no no patient 2 clogging
3 58.6 no no patient 3 clogging
4 57.9 no no patient 4 aggregate formation
5 69.0 no no patient 5 aggregate formation
6 0 yes no healthy 1 aggregate formation
7 58.2 no yes patient 4 aggregate formation
8 62.8 no no patient 6 aggregate formation
9 90.0 no no patient 7 aggregate formation
10 0 no no healthy 1 control (no HbS)
11 0 no no healthy 2 control (no HbS)
12 0 no no healthy 3 control (no HbS)
Biophysical Journal 108(11) 2623–2632of five days after venipuncture. Before any experiment, the SRBCs were
diluted to a hematocrit value of 25% typical of the physiological
microcirculation.
Samples for experiments that address the question of the presence of free
HbS in solution were prepared using healthy RBCs washed as previously
described. Before the experiment, RBCs were suspended in a buffer that
consisted of a 3-day-old supernatant of washed SRBC sample (PBS þ
5 mM glucose at 300 mOsm), containing a small amount of free HbS in so-
lution, due to hemolysis (sample 6).
Samples used to investigate the effects of plasma proteins, platelets, and
white blood cells were prepared from washed SRBCs that are suspended in
autologous plasma containing platelets and white blood cells. The resulting
white blood cell count was estimated by visual counting under a microscope
and was ~0.1%.Microfluidic channels
Devices are fabricated using the classical soft-lithography with replica
molding method (23) (the detailed procedure is described in the Supporting
Material). We mold the devices using a silicone elastomer, PDMS (polydi-
methylsiloxane), which is porous to gases (24). We use this feature to
control the oxygen concentration in the channels via a two-layer PDMS
structure. The first layer of 60 mm in thickness is engraved with channels
of 30 mm in height where RBCs should flow. This layer is bonded to a glass
microslide by plasma bonding. The plasma treatment has to be fast (few
seconds) because of the fast decrease of permeability of PDMS with expo-
sure time to the corona discharge (25). The second layer, dedicated to the
gas flow, is plasma-bonded on the top of the first one and engraved with
a long serpentine channel of 500 mm in width and 80 mm in height. It covers
the entire surface of the chip (see Fig. 1) to maximize gas exchange. RBC
channels and gas channels are thus separated by a 30-mm-thick PDMS
membrane through which oxygen diffuses. The geometries of the microflui-
dic chips are shown in the Fig. 1. They all contain a deoxygenation chamber
that consists of a large, rectangular, 2-cm-long and 4-mm-wide section,
supported by pillars to prevent the top surface from collapsing onto the
glass slide. Downstream from the deoxygenation chamber, we have the
microcirculation section. On the first chip (chip 1), the microcirculation
section consists of a region containing triangular pillars to mimic corner
flows, followed by a section of sixteen 1-cm-long and 30-mm-wide parallel
channels (see Fig. 1 b) to test the clogging hypothesis. On the second chip
(chip 2), the microcirculatory section consists of successive branchings of
20-mm-wide channels (Fig. 1 c).RBCs deoxygenation protocols
To optimize the deoxygenation rate, the gas exchange surface is large, with
a 30-mm-thick membrane separating the gas channels from the flow of
RBCs. In such a device, gas exchange is known to occur over tens of
seconds (24,26,27). This timescale has to be compared with the time for
a RBC to flow along the deoxygenation chamber, which is of the order of
minutes. When the RBCs reach the microcirculatory part, they are already
deoxygenated if pure nitrogen is injected in the serpentine channel. To satu-
rate the PDMS chip, we initiated the gas flow 30 min before the injection of
RBCs. The gas flow is maintained throughout the experiment. RBCs are
therefore deoxygenated while flowing.Experimental setup
Observations are performed on an inverted microscope and the temperature
surrounding the microfluidic chips is maintained at 37C by an air flow in
all experimental conditions. The gas channel is directly linked to a pressure
controller (Fluigent-4C, four independent channels; Fluigent, Lowell, MA)
and RBCs are injected from a pressurized tube that is linked to the pressure
FIGURE 1 Microfluidic channel geometry. (a) Overlay of the geometry
of the gas channel (light gray) and the channel network for the RBC suspen-
sion (black). The gas channel, a 500-mm-wide and 100-mm-high coil, covers
the entire surface of the chip to promote and control gas exchange within
the RBC channels. (b) Geometry of RBC channels of chip 1. RBCs are
deoxygenated during their flow through the gas exchange chamber. In
the zoom-in window, microcirculation section consisting of a region of
triangular pillars followed by sixteen 1-cm-long and 30-mm-wide parallel
channels. (c) The microcirculation section consists of 20-mm-wide channels
that successively branch, for chip 2. Scale bars, 2 mm. To see this figure in
color, go online.
Deposition at Acute Corners of SRBCs 2625controller. Microfluidic channels have been designed to obtain a configura-
tion with characteristic length, velocity, and hematocrit conditions similar
to that encountered in the microcirculation (18). The total pressure differ-
ence used to induce the flow is 130 mbar. Given the typical length of the
devices we use, this value yields a pressure drop per unit length of ~0.1
Pa/mm, typical of the microcirculation (28). Characteristic velocities of
RBCs measured in the middle plane of the 30-mm channels are, depending
on this input pressure, of ~7 mm/s to mimic the postcapillary venules blood
circulation (28). Around the triangular pillars studied here, the velocity
ranges from 100 to 400 mm/s, closer to capillary flow velocities (29).RESULTS AND DISCUSSION
We first test the clogging hypothesis at the microcirculation
scale using chip 1. While no occlusion has been observed in
the 30-mm-wide microchannels, even after 2 h of flow, weobserve the deposition of SRBCs into large aggregates at
acute corners in the microfluidic device. These aggregates
contain both SRBCs and healthy RBCs, because our
samples are all from exchange transfusion patients. Never-
theless, we verified that neither healthy nor sickled RBCs
enter the microchannels as clusters; and as we will show
later, neither deposition nor aggregation in flow occurs
only with healthy RBCs.Role of the flow geometry
We focus our attention on the triangular pillars whose acute
corners both upstream and downstream mimic locally the
fast variation of direction of the streamlines observed at bi-
furcations in the microcirculation. We observe the formation
of SRBCs aggregates on one pillar first at the two corners sit-
uated downstream (chip 1) and later at the opposite corner
upstream (chips 1 and 2) as shown in Figs. 2, a–c, and 3.
The deposition is slow and a delay time of 20 min is
observed before the onset of growth, which results from suc-
cessive and accumulative adhesion of SRBCs. The cells
form layers and the flow pushes slowly the whole aggregate
on each side toward the center of the triangular pillar base.
This leads to the formation of a single large aggregate after
~1 h of flow (Fig. 2 c; Movie S1 in the Supporting Material).
Deposition at the upstream front of the pillar results in the
formation of an aggregate on each side (Fig. 3, a–c). This
deposition is observed to be slower than the one down-
stream.When observed in branching channels (chip 2), these
aggregates reach a critical transverse size up to one-half of
the total channel width (Fig. 3 d). This is due to a continuous
increase of the shearing force during deposition due to chan-
nel lumen reduction. Above this critical size, we observe
some additional SRBCs that transiently bind to the aggregate
with a residence time ranging between 2 and 13 s. The intri-
cate interaction between the flow and the aggregate develop-
ment at branches leads us to focus this study of deposition
around the pillars walls where the flow is not confined.
Interestingly, no deposition is initiated on the substrate or
the ceiling of the chips on the timescale of the experiments.
Deposited aggregates are observed waving in the flow and
are found to be best focused around the half-height of the
channel. They can break or detach from the pillars, but
this remains a rare event.
We characterize the temporal evolution of the size of
different SRBCs aggregates at the rear of the pillars using
samples 4, 8, and 9 at 25% hematocrit (similar to venules
hematocrit), as shown in Fig. 2 g. SRBCs are deoxygenated
while flowing. Initially, only a few RBCs adhere behind
the pillar, and during 15–20 min there is no major evolution.
Then, an aggregate develops from each corner of the trian-
gular pillar and finally merge after 1 h. This sequence
is shown for sample 4 in Fig. 2, a–c. The resulting aggre-
gate still grows to reach a steady length of several tens
of microns. The aggregate redefines the boundary of theBiophysical Journal 108(11) 2623–2632
ab e
c f
d
g
FIGURE 2 Morphology and time evolution of aggregates at the rear of
pillars. (a–c) SRBCs from sample 4: pictures of aggregate formation at
the rear of a pillar. For t ¼ 10 min, only a few cells are in adhesion on the
PDMS pillar. After 30 min, an aggregate has grown on both corners at the
rear of the pillar. After 60 min, the two aggregates merge and the length
remains stable. Scale bars, 20 mm. (d–f) Healthy RBCs deposition on pillars
(sample 10). Only a few cells stick to the pillar. Scale bars, 20 mm. (g) Tem-
poral evolution of the length of SRBCs aggregate at the rear of pillars
(sample 4, red circle; sample 8, orange triangle; sample 9, green square;
25% hematocrit). The aggregate length is defined as the maximum extent
from the base of the pillar and the fluctuating end. For t < 15 min, only a
few cells are in adhesion on the PDMS pillar. Then the growth initiates
and aggregates can reach a size of ~40 mm. For each curve, the length is
averaged over seven different aggregates. Control experiment, with healthy
RBCs: only few of them stick to the PDMS pillar (blue diamonds, sample
10, 25% hematocrit). To see this figure in color, go online.
2626 Loiseau et al.triangular pillar, reducing the local curvature of the stream-
lines and hindering further deposition. The aggregate length
saturates when the angle of the corner that is initially close
to 60 reaches ~120. Control experiments were performed
on the same timescales with healthy RBCs (same MCHC).
They show that only a few RBCs stick at the corners of
the pillars (blue curve in Fig. 2 g; pictures in Fig. 2, d–f,
and Fig. S2 in the Supporting Material).
Our microfluidic assay points out that acute corners are a
location of much higher capture frequency and a place forBiophysical Journal 108(11) 2623–2632aggregates to grow, as also observed for biofilm growth of
dilute solutions of bacteria (30). The formation of SRBCs
aggregates on the vertical walls of the pillars, where the
flow changes direction, is to be correlated with the few
in vivo images of the onset of deposition available in the
literature (31–33). In these studies, aggregates are present
at blood vessel bifurcations where strong bends are present,
similar to the flow geometry around the triangular pillars in
our microfluidic chips.
The hydrodynamics of concentrated suspensions around
corners at low Reynolds number seems to play a funda-
mental role in the cellular deposition. To describe the flow
in this region, we use cross-correlation image velocimetry
(using the software IMAGEJ, National Institutes of Health,
Bethesda, MD, and its particle image velocimetry plugin)
around one pillar to obtain the local average velocity field
and the associated streamlines for SRBCs flowing in the
middle plane of the channel. The streamlines are reported
in Fig. 4 a, together with the trajectories for seven SRBCs
followed by hand at different initial distances from one of
the pillar edge. We compare these lines with those of the
suspending fluid flow only (without cells, white streamlines
in Fig. 4 a), computed using an in-house three-dimensional
flow solver (34) (YALES2BIO, details in the Supporting
Material) around a pillar of the same geometry. The creep-
ing flow (the Reynolds number is ~0.0028) is computed
around an infinite array of pillars, using periodic conditions
in the directions tangential to the wall. The comparison
reveals that downstream of the pillar, the SRBCs streamlines
are contracted toward the pillar basis compared to the three-
dimensional computed flow of a simple Newtonian fluid in
the same geometry. On average, there is a net transverse
drift of the cells toward the base (on each side of the pillar)
in the region of maximum rotation of the streamlines. This
observation could explain the higher collision rate of the
SRBCs in this region leading to a higher deposition rate.
Furthermore, the cells can explore the otherwise excluded
region behind the pillar around the corner. Deformable ob-
jects such as RBCs circulating near a flat wall are known
to be driven away from the wall by a lift force (35,36) at
the origin of the cell-free layer in the microcirculation.
This force prevents RBCs from adhering to vessels wall.
This is not the case here, notably due to the presence of
corners and multibody interactions. The contraction of the
streamlines we see, compared to the three-dimensional
Newtonian case, seems to indicate the non-Newtonian
nature of this effect.
To illustrate the link among flow geometry, inverse-lift,
and multibody interactions, we perform complementary
simulations of one and two deformable two-dimensional
capsules flowing around a pillar using our in-house
flow solver. The capsules are supposed to be inextensible
and resist bending. Their dynamics and deformation is
computed using a full fluid-structure interaction approach
and results are displayed in Fig. 4, b and c. All the technical
a b c d
FIGURE 3 Morphology of SRBC aggregates at the front of pillars. (a–c) Aggregation over time at the front of a pillar (sample 4). (d) Aggregate at a
branching point in 20-mm-wide channels (geometry Fig. 1 c), observed after 2 h of flow. In this geometry, the aggregate can grow up to half of the channel
width (sample 5). Scale bars, 20 mm.
Deposition at Acute Corners of SRBCs 2627details and assumptions are provided in the Supporting
Material. In the case of a single capsule, the shortest dis-
tance between the capsule membrane and the wall always
increases, except at the corner, where the flow slightly
accelerates. On the other hand, a capsule may follow a
different trajectory if a second capsule follows it. In the
corner case displayed in Fig. 4 b, the front capsule stays
closer to the corner and remains close to the pillar wall
beyond the corner in a zone of lower speed. If the cells
are close to each other at the right moment when passing
the corner, their hydrodynamic collision produces a transi-
tory pairing (due to lubrication forces) that drives the cluster
in an otherwise forbidden region during rotation. We then
compared this situation with a second test case shown in
Fig. 4 c with the same capsules in a simple two-dimensional
Couette flow between two flat walls (configuration shown in
Fig. S5 b). The model, grid resolution, and the characteristic
parameters (shear rate, capillary number, Reynolds number,
bending coefficient) are strictly identical to the case of flow-
ing capsules around a pillar. In this Couette flow, the shear
rate is constant and identical to the one seen by the capsules
when they flow along the lateral wall of the pillar. Couette
flow simulations were used as control cases, to confirm
that the specific results obtained around the pillar are related
only to the flow geometry. In the Couette flow, capsules
simply interact by switching positions, as observed in com-
putations of two interacting vesicles or capsules (37) in the
presence of a wall. The specific phenomenon shown in the
article of capsules exploring regions very close to the pillar
wall is thus the result of a combination between geometrical
characteristics of the corner and multibody effects. This
behavior increases the probability for the cells to stick to
each other and to adhere at this specific location, and may
participate in the formation of an aggregate at the corner.
In general, it has been demonstrated that the highly bifur-
cating topology of the microcirculatory network causes
RBCs from side branches to be frequently introduced into
the region closest to the wall at each branch, as shown for
instance in the vascular bed of the rat spinotrapezius muscle
(19), preventing the development of a significant cell free
layer in networks. This phenomenon is also observedin vitro around our pillars or at our microfluidic bifurcations.
Such modifications would also promote adhesion, but
further studies both in vitro and in vivo are necessary to
understand how flow patterns such as the bifurcation angle
and flow direction could promote deposition and lead to
occlusion.Role of oxygen
We test the role of oxygen on the formation of aggregates
using chip 1 (Fig. 5). Starting from a long aggregate formed
under deoxygenated conditions, we replace the nitrogen
in the gas channel with air. First, the aggregate becomes
more floppy due to the depolymerization of HbS within
the SRBCs. Second, the cells detach and the aggregate
shortens during 10 min. Then, third and finally, the aggrega-
tion process restarts in oxygenated conditions and the
aggregate recovers the same size reached under nitrogen
conditions. More generally, oxygen does not prevent aggre-
gate formation at the pillar corners. Indeed, when we initiate
the flow under oxygenated conditions, we observe the
growth of RBC aggregates of the same size, in contrast to
those found in the absence of oxygen (see Fig. S3). It is
interesting to notice that aggregates made of oxygenated
SRBCs exhibit a different appearance as well. Oxygen-
ated SRBCs are more deformable due to the absence of
HbS polymer and thus, they better align, according to
the streamlines, into layered stacks of cells (Fig. 5 d and
Movie S2). Notable, as in the deoxygenated case, the
aggregate surrounds the pillar, reducing locally the curva-
ture and hindering further growth.Role of the presence of free hemoglobin and the
products of hemolysis
People suffering from sickle cell anemia have a higher
amount of free hemoglobin in their blood plasma due to
a higher intravascular hemolytic rate (38). Furthermore,
some studies report on the possibility for hemoglobin to
bind to the RBC membrane (39,40). We investigate in this
section whether the presence of products of hemolysisBiophysical Journal 108(11) 2623–2632
FIGURE 4 SRBCs flow around corners. (a) (Triangle symbols) Individ-
ual trajectories of SRBC. (Red streamlines) SRBC flow field computed
by particle image velocimetry. The SRBC flow field contracts at the rear
of the pillar compared to the creeping flow of a Newtonian fluid (white
streamlines). (b) Simulation of deformable two-dimensional capsules
flowing around a corner: the distance d of a capsule to the pillar wall,
normalized by the capsule characteristic size R, is represented over time.
The comparison between the trajectory of a single capsule (black curve)
and trajectories of two consecutive capsules (red and blue curves), points
out multibody effects: in the displayed case, consecutive capsules flow
closer to the corner wall than a single capsule. Moreover, when two consec-
utive capsules flow around the corner, the second capsule may push the first
one closer to the wall at the corner (inset 2 b) and at the rear (inset 2 d), as in
the simulation shown here. (c) Simulation of deformable two-dimensional
capsules flowing along a flat wall in a Couette flow: same legend as (b). To
see this figure in color, go online.
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2628 Loiseau et al.(PHemo), which contain free HbS, could be an enhancing
factor for the formation of cellular aggregates. In the chan-
nels, we inject healthy RBCs suspended at 25% hematocrit
in the supernatant of initially washed SRBCs samples kept
in the fridge (PBSþ 5 mM glucoseþ PHemo; see Materials
and Methods), which contains free HbS due to hemolysis
(sample 6). The evolution of the average aggregate length
over time is then reported in Fig. 6. Aggregates grow after
~20 min, as previously observed in the case of SRBCs, but
reach a constant length of 185 1.5 mm after 80 min, three
times shorter than for the SRBCs aggregates. When the
same experiment is performed with RBCs suspended in a
supernatant of healthy RBCs (see Materials and Methods)
containing free HbA instead of free HbS and all the same
products of hemolysis, we do not observe aggregate forma-
tion similar to the former case (blue curve in Fig. 6).
Free HbS and its derivative products seem to play a role in
the adhesive nature of RBCs. However, this is not sufficient
to obtain aggregates on the order of 50 mm. HbS is usually
submitted to a high rate of autooxidation, particularly when
it is not encapsulated in RBCs. The generation of oxygen
free radicals may cause severe RBCs membrane damage,
hence changing the rheological and adhesive properties of
flowing RBCs. It was previously reported that oxidative
stress is able to decrease RBCs deformability (41), increase
RBCs aggregation strength, and promote the adhesion of
RBCs to endothelial cells (42,43). Indeed, it may be specu-
lated that increased adhesion and RBC aggregate formation
at a corner in the presence of free HbS could be related to
increased oxidative stress. These questions need further
investigation in order to better understand the proadhesive
properties of SRBCs.Effect of autologous plasma in combination with
platelets and white blood cells
Since the 1990s, numerous factors have been identified as
potentially involved in vaso-occlusive mechanisms (14,17).
These include the presence of proteins in the plasma, platelets,
and WBCs. We explore the potential role of these elements
on the aggregate formation in our microfluidic chips by
adding autologous plasma containing platelets and WBCs
to SRBCs (blood sample 7). The final WBCs count was
~0.1%. We observe the formation of cellular aggregates but
the morphology is completely different. In this case, aggre-
gates form long chains, waving in the flow, which can reach
several hundreds of microns (Fig. 7 b andMovie S3). SRBCs
in these aggregates are elongated and adopt a tear drop shape,
forming tethers. On Fig. 7, we can distinguish the membrane
tube linking the pillar to the first RBC aswell as aWBC in the
aggregate. Contrary to previous observations, the growth of
these aggregates appears to be randomly distributed in time.
They can form within the first minutes of flow and on a time-
scale of seconds. In the control experiment with healthy cells,
we do not obtain such structures.
a
b
c
d
FIGURE 5 Oxygen does not prevent aggregate formation. (a) Time evo-
lution of SRBCs aggregates at the rear of a pillar in the absence or presence
of oxygen (sample 4). Under deoxygenated conditions, the aggregate grows
as previously described, to reach a stable length of 45 mm. Then, nitrogen is
turned off in the gas channel and replaced by oxygen at t ¼ 80 min. HbS
polymer in SRBCs depolymerizes, which results in more deformable
SRBC and a rearrangement of the aggregate. The length of the aggregate
decreases to 20 mm before recovering its initial length 20 min after oxygen
injection. (b–d) Snapshots of the aggregate morphology in presence or
absence of oxygen; the time refers to the evolution in (a). Blood sample
number 4 at 25% hematocrit is used. Results of a control experiment
with healthy RBCs are also shown (blue triangles, sample 10). To see
this figure in color, go online.
FIGURE 6 Free HbS promotes aggregation. Evolution of aggregates
for healthy RBCs flowing in a medium that contains free HbS (blood
sample 6, red circles) and for healthy RBCs with free HbA in solution
(blue triangles). The length is an average over 10 aggregates. To see this
figure in color, go online.
Deposition at Acute Corners of SRBCs 2629We still do not know the respective role of platelets or
WBCs in the formation of these structures and the origin
of the membrane forming the filaments. However, recent
observations show a preferential adhesion of WBCs at
bifurcations (44), independent of the endothelium state,
which could result from local hydrodynamical conditions.
In addition, RBCs-WBCs interactions are known to be
important in postcapillary venules (32) and WBCs from
SCA patients seem to be more adhesive to SRBCs (45)
and are capable of forming aggregates of few cells in whole
blood (46). Moreover, the drastic morphology change we
observe for the aggregate could be correlated to the known
activation of platelets observed during blood storage at 4C
(47,48). It has been reported in particular that activated
platelets are able to form aggregates in a shear microgra-
dient (49), in locations analogous to the corner of the pillars
of this device, but for much higher Reynolds number flow
conditions, not relevant for the microcirculation. Further
experiments are required to determine the specific role of
the platelets or WBCs during aggregate formation. A first
step would be to label their membrane with different dyes
to track their positions within an aggregate.Vaso-occlusion: two hypothetical scenarios
All the observations reported above provide information to
propose two hypothetical scenarios for vaso-occlusion tooccur at bifurcations in vivo, as illustrated in Fig. 8 a.
Aggregation present at corners could either reduce vessels’
diameter (as seen at bifurcations in Fig. 3 d) until occlusion,
and/or large aggregates could be shed randomly in time
disturbing the flow downstream. We observed in rare occa-
sions the breaking of the aggregate (Fig. 8 b and Movie S4)
and its passage through a 30-mm channel. We succeeded in
recording one passage event in a slightly different chip
where the region of 30-mm channels was replaced by an
array of 20-mm channels flowing at different intersection
angles into a main output channel (see geometry in the Sup-
porting Material). This passage is shown in Fig. 8 c. When
the aggregate enters upstream of the field of view, the entire
flow in the channel decreases. When the aggregate reaches
the field of view, we observe downstream of it a depletion
in SRBCs, while upstream the SRBCs density is higher.
This critical situation leads to a dramatic drop of the average
flow velocity (down to 15% of its initial value as shown in
Fig. 8 c), and could promote further HbS polymerization
and aggregation of the SRBCs behind the aggregate. This
would lead to flow regimes close to the ones where jamming
was observed in microfluidic devices (26). However, we
were never able to observe total occlusion in our devices,
but this is consistent with the fact that blood samples
came from patients that are regularly transfused to prevent
frequent vaso-occlusive crises. In addition, other factors
listed by Switzer et al. (38) such as platelets aggregation,
vasoconstrictive molecules (endothelin family proteins),
and decreased nitric oxide bioavailability, will certainlyBiophysical Journal 108(11) 2623–2632
FIGURE 8 Suggested scenario. (a) The formation of microthrombi at a
corner or at branching points can drastically impair the hemodynamics,
due to a possible severe restriction of the lumen area. (b) Example of aggre-
gate detachment (blood sample 8 at 25% hematocrit): when reaching a crit-
ical size, cellular aggregates can break. Scale bar, 20 mm. (c) Free flowing
aggregate in microcirculation. Relative velocity of an aggregate flowing
along a 20-mm-wide channel. Initial velocity is 200 mm/s and SRBCs
were from blood sample 8 at 25% hematocrit. (Open arrows) Direction
of the flow. To see this figure in color, go online.
FIGURE 7 Morphology of SRBCs aggregate in the presence of autolo-
gous plasma, platelets, and WBCs. (a) SRBCs from sample 7. The aggre-
gates are long chains fluctuating in the flow. They can reach several
hundreds of microns long. We can distinguish the membrane tube linking
the pillar and the first RBC. The picture has been taken after the RBCs
had cleared the channel but there is still some media flowing in the channel.
This allows a better observation of the aggregate structure. The term
l defines the length of the aggregate. Scale bar, 20 mm. (b) Aggregates’
length in presence of autologous plasma, platelets, and x0.1% WBCs,
sample 7 (green diamonds). The control corresponds to healthy RBCs
(blue triangles, sample 10). To see this figure in color, go online.
2630 Loiseau et al.act together with the hydrodynamic conditions at corners
to promote deposition and aggregation of SRBCs and to
participate in a vaso-occlusive crisis.CONCLUSIONS
Microfluidics is a suitable tool to study blood circulation
at the microcirculatory level. In this study, we reported
on SRBCs’ aggregation at bifurcations and around acute
corners. We have shown that the geometry of the flow is a
key factor for the formation of SRBCs aggregates. The onset
of aggregation results from an intricate interplay among
geometry, collective motions, and proadhesive properties
of SRBCs, and remains to be fully explored and understood.
Moreover, the origin of SRBCs’ adhesiveness at the heart
of our observations is still an open question, and measuring
the strength of adhesion would give some better insights on
its importance in the context of cellular deposition in flow.
In addition, it would be interesting to extend this microflui-
dic study to different hematocrit and healthy/sickled RBCs
proportions, as well as to research actively the signs of
such corner-flow-enhanced deposition and aggregation
in vivo and its consequences on vaso-occlusion.
Finally, we hope that our preliminary results will moti-
vate future studies on the role of flow geometry in cellBiophysical Journal 108(11) 2623–2632capture not only during vaso-occlusion but also in other
physiologically relevant situations like the inflammatory
response.SUPPORTING MATERIAL
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